EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

EXAS News and Commentary

Caps

How do you think EXAS will perform against the market?

Add Stock to CAPS Watchlist

All Players

244 Outperform
47 Underperform
 

All-Star Players

45 Outperform
21 Underperform
 

Wall Street

13 Outperform
1 Underperform
 

Top EXAS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ELPastor (< 20)
Submitted October 27, 2014

Most people, it is safe to say, do not enjoy getting a colonoscopy. Therefore, any company that offers a non-invasive colorectal cancer screening test has a good chance of squeezing out a nice, large profit.

zzlangerhans (99.82)
Submitted June 26, 2016

Exact stock does well when something happens to fuel speculation about the long-term profitability of Cologuard, and badly when actual quarterly revenues and losses are released. That reminds me of another stock that has a large cult following and… More

EXAS VS S&P 500 (SPY)

Fools bullish on EXAS are also bullish on:

Fools bearish on EXAS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EXAS.

Recs

0
Member Avatar 407rotorhead (33.04) Submitted: 10/20/2017 3:41:12 PM : Outperform Start Price: $48.94 EXAS Score: -0.29

Age increasing in population requiring colon screenings. This is an easy way to complete these screenings. Medicare approved.

Recs

0
Member Avatar TMFTypeoh (85.93) Submitted: 8/17/2017 2:18:24 PM : Outperform Start Price: $37.73 EXAS Score: +26.22

Willing to green thumb this high flyer even though valuation is crazy.

Recs

0
Member Avatar DADDYBLAME (66.85) Submitted: 6/9/2017 10:35:46 AM : Outperform Start Price: $14.14 EXAS Score: +251.77

This stock was a no brainer for me after I read that it had developed a non intrusive test for colon cancer testing. I picked it up in January of 2017 at around $14.00 a share before it started to go higher. Like most people,I did not look forward to the traditional colonoscopy, in fact kept putting it off, so ala Peter L thought it had a reasonable chance to go higher. Will be ordering this for myself as soon as doctor gets back from vacation. Sometimes the blind squirrel finds a nut!

Leaderboard

Find the members with the highest scoring picks in EXAS.

Score Leader

proisback

proisback (55.26) Score: +1,580.24

The Score Leader is the player with the highest score across all their picks in EXAS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
proisback 55.26 9/24/2009 Outperform 3M $2.88 +1,743.06% +162.81% +1,580.24 1 Comment
theonlypro4U < 20 9/23/2009 Outperform 3M $2.89 +1,736.68% +159.96% +1,576.72 1 Comment
chas1232123 < 20 9/23/2009 Outperform 3Y $2.91 +1,724.12% +161.27% +1,562.85 1 Comment
coolyo514 82.46 12/17/2009 Outperform 5Y $2.94 +1,706.61% +153.04% +1,553.57 0 Comment
DUTCHMAN67 62.33 12/17/2009 2/16/2012 Outperform 5Y $2.96 +1,693.85% +153.54% +1,540.30 0 Comment
JavaChipFool 70.46 12/22/2009 Outperform 5Y $2.97 +1,687.15% +150.10% +1,537.05 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. pantastic 77.51 12/17/2009 Outperform 5Y $2.98 +1,681.27% +153.38% +1,527.88 0 Comment
NickJ100 77.41 12/17/2009 9/24/2014 Outperform 1Y $3.01 +1,663.46% +152.86% +1,510.60 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jpmj 69.83 12/18/2009 11/23/2014 Outperform 5Y $3.05 +1,640.33% +154.84% +1,485.49 0 Comment
JordanKay36 < 20 12/18/2009 Outperform 5Y $3.06 +1,634.64% +153.77% +1,480.87 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.32 5/3/2017 Outperform 3W $31.31 +69.53% +17.27% +52.26 0 Comment
trackcraighallum 52.90 6/16/2016 Outperform NS $9.92 +435.08% +35.28% +399.80 0 Comment
TrackJimCramer 85.32 7/22/2015 Underperform 3W $25.29 +23.80% +12.87% -10.94 5/3/2017 @ $31.31 0 Comment
TrackGoldmanSach 81.28 6/4/2014 Outperform NS $14.20 +273.80% +45.30% +228.50 0 Comment
TrackRothCapital 72.55 12/20/2012 Outperform NS $10.43 +408.92% +93.70% +315.22 0 Comment
TrackUltraLong < 20 2/6/2012 Underperform NS $9.57 +454.65% +108.16% -346.49 1 Comment
TrackCanaccord < 20 1/6/2012 Outperform NS $8.41 +531.15% +118.14% +413.01 0 Comment
TrackJMP 83.22 1/5/2012 Outperform NS $8.12 +553.69% +120.66% +433.04 0 Comment
TrackRodmanRen < 20 8/15/2011 Outperform NS $6.74 +687.54% +134.63% +552.90 0 Comment
TrackWedbush 87.31 6/28/2011 Outperform NS $8.03 +561.02% +117.72% +443.30 0 Comment
TrackTheBenchmar 77.24 4/28/2011 Outperform NS $7.45 +612.48% +106.50% +505.99 0 Comment
TrackAurigaUSA 40.31 3/1/2011 Outperform NS $5.65 +839.47% +109.37% +730.10 0 Comment
TrackWMBlair 80.50 12/14/2010 Outperform NS $5.72 +827.97% +123.69% +704.28 0 Comment
TrackJimCramer 85.32 10/13/2010 Outperform 3W $8.39 +201.43% +79.18% +122.25 7/22/2015 @ $25.29 0 Comment
TrackJefferies 77.89 9/9/2010 Outperform NS $5.17 +926.69% +150.48% +776.21 0 Comment
TrackRWBaird 88.62 3/4/2010 Outperform NS $4.25 +1,148.94% +148.70% +1,000.24 0 Comment
TrackRodmanRen < 20 2/2/2010 Outperform NS $4.25 +80.24% +14.87% +65.37 8/3/2011 @ $7.66 0 Comment

Featured Broker Partners